scores were lower than the norm post-op for all breast cancer patients.
PURPOSE:
Despite associations with greater quality of life, autologous transfer represents a declining proportion of US breast reconstructions. Poor physician reimbursement relative to prosthetic reconstructions may be a barrier contributing to this trend. The study aims to evaluate the impact of relative physician payments for common methods of immediate breast reconstruction (IBR).
METHODS:
Following IRB approval, the Blue Health Intelligence (BlueCross/BlueShield) national claims database was analyzed from 2009 through 2013. Procedural volume and payments for plastic surgeon professional services were calculated for two common IBR methods: tissue expander (TE) and free flap (FF).
RESULTS:
Of 25,209 patients who had IBR, 84.4% received tissue expanders (TE) and 15.6% underwent free flaps(FF). Five-year growth-rate in TE: FF was 4.3%. Average physician payment increased 18% for TE versus 14% for FF. Payment variation, expressed as the standard deviation relative to mean, was significantly greater for FF (116%) than TE(59%). Markets that experienced a $1,000 gain in TE payment, increased the TE:FF on average 103% (p<.05). The same gains in FF payment increased the FF:TE by 74% (p<.05).
CONCLUSION:
Physician payments are increasing at a greater rate for TE than FF. Markets are significantly more responsive to payment changes in TE than FF, suggesting larger scale changes in payment would be needed to influence flap growth. An alternative interpretation is that barriers beyond reimbursement may influence the number of FF performed. Larger payment variation for FF supports greater room for reimbursement negotiation. 
PURPOSE:
Pedal fat pad atrophy is a devastating condition affecting 30% of patients over the age of 60 and impacting foot function, pain, and appearance. We have previously reported in a one-year randomized clinical trial that fat grafting to the foot results in statistically significant improvements in pain and quality of life outcomes, despite fat loss over time. We hypothesize that pedal fat grafting may benefit dermal and soft tissue thickness, which may account for the prolonged symptomatic improvement despite loss of the grafted fat.
METHODS:
Patients with fat pad atrophy of the forefoot were enrolled into a randomized cross-over clinical trial. Group 1 underwent fat grafting immediately upon enrollment with 2-year follow-up. Group 2 was managed conservatively for 1 year upon enrollment then crossed over into the fat grafting group with 1-year follow-up. Fat was harvested utilizing the Coleman method and an average of 4-6 ccs of fat were injected into the ball of each affected foot. Patients followed up at 1, 2, 6 and 12 months postoperatively, at which times pedal ultrasounds were performed to determine thickness of the fat pad and the dermis overlying each metatarsal head. Over the course of the study period, the Manchester Foot Pain and Disability Index, a validated survey assessing functional limitation, pain intensity, and personal appearance, was administered to study participants.
RESULTS: 3 men and 20 women were included in the study with an average age of 63 (±6 years). The average BMI was 26.0 (±4.6 kg/m 2 ). 26 feet were injected in Group 1, and 17 were injected in Group 2. There was no variance in BMI or age across groups. In Group 1, fat pad thickness was increased until 12 months postoperatively (p<0.05). In Group 2, fat pad thickness was increased until 6 months postoperatively (p<0.05). In Group 1, dermal thickness was greater in the 5 th metatarsal at 12 months postoperatively (p<0.05). However, this difference was clinically negligible. In Group 2, there was no significant difference between dermal thickness preoperatively and at 12 months postoperatively. With regard to clinical outcomes, Group 1 had significant improvement in pain through 24 months (p<0.001) and foot function through 18 months post-injection (p<0.05). Group 2 had significant improvement in pain and increased work and leisure activities through 6 months post-injection (p< 0.05).
CONCLUSIONS:
Though fat grafting for pedal fat pad atrophy has minimal effect on the dermis 1 year after injection, it does have a significant impact on pain and function. These quality of life measures demonstrate a persistent improvement for up to 2 years, though fat volume is only shown to persist until 1 year. Future studies are planned to evaluate the hypothesis that these findings may be attributed to dispersion of the grafted fat over time, allowing for fat-mediated rejuvenation of the pedal tissue without a measurable impact on fat pad or dermal thickness. Given the impact of pedal fat grafting on function, pain, and quality of life, this technique may present a longterm solution for patients with debilitating fat pad atrophy. 
TRACHEAL TISSUE-ENGINEERING: EPITHELIAL GRAFTING OF GENTLY-DECELLULARIZED RABBIT TRACHEA
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INTRODUCTION:
Long-segment tracheal pathologies are associated with high morbidity and mortality. Despite a relatively straightforward anatomy of the trachea, reconstruction might be deceptive. Key elements of successful transplantation include the use of a biocompatible construct with little immune-reactivity, vascularization of the submucosal lining and creation of an inner epithelial covering. Our aim was to evaluate the in-vivo response of gently-decellularized rabbit trachea grafted with buccal mucosa, after revascularization within the lateral thoracic artery flap.
MATERIALS AND METHODS:
Ten allogenic rabbit tracheae underwent two cycles of detergent-enzymatic decellularization with 4% sodium deoxycholate, 50 kU/ml DNAse and distilled water. Subsequently, scaffolds were implanted within the lateral thoracic artery flap of ten New Zealand White Rabbits. After revascularization, decellularized tracheae were grafted with buccal mucosa. Macroscopical, histological analysis and immunohistochemistry were performed on explants at termination.
RESULTS:
Revascularization of the inner lining was incomplete in the first two circular constructs. These tracheae showed only partial ingrowth of the graft on the edges. The following eight transplants were opened longitudinally before implantation. Consequently, the submucosal space of all constructs revascularized well within 14 days. Also graft-adherence was complete in these tracheae. Mild calcification of the cartilage was noted in three tracheae. Moderate lymphocytic infiltration within the buccal graft was detected in three specimens.
CONCLUSIONS:
Gentle detergent-enzymatic treatment of rabbit tracheae efficiently removed all noncartilaginous cells. Moreover, this technique preserved the submucosal scaffold and basement membrane, both essential to guide revascularization and reepithelialization respectively. Decellularized tracheae exhibited beneficial in-vivo properties. By opening the transplant, insufficient revascularization through inter-cartilaginous ligaments could be overcome successfully. The scaffold also proved to offer a suitable matrix for epithelial covering. To further enhance our results, the next step is to provide a functional epithelial covering. Therefore, we are currently focusing on
